tiprankstipranks
Trending News
More News >
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
US Market

Compare Actuate Therapeutics, Inc. (ACTU) vs. Competitors

Compare
25 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Actuate Therapeutics, Inc.
$6.28
$150.85M
-5.19
-21.50%
2 Buy
0 Hold
0 Sell
Moderate Buy
Agenus
$4.34
$125.83M
-1.76
10.29%
1 Buy
0 Hold
0 Sell
Moderate Buy
Black Diamond Therapeutics
$2.78
$154.40M
7.66
36.95%
4 Buy
1 Hold
0 Sell
Strong Buy
Nkarta
$2.11
$146.32M
-1.52
-11.72%
4 Buy
1 Hold
0 Sell
Strong Buy
C4 Therapeutics
$2.19
$215.15M
-42.97%
3 Buy
0 Hold
0 Sell
Strong Buy
Kyverna Therapeutics, Inc.
$8.45
$497.03M
-2.27
122.37%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ACTU
Actuate Therapeutics, Inc.
6.28
-2.02
-24.34%
AGEN
Agenus
3.75
0.63
20.19%
BDTX
Black Diamond Therapeutics
2.78
0.85
44.04%
NKTX
Nkarta
2.11
-0.24
-10.21%
CCCC
C4 Therapeutics
2.19
-1.47
-40.16%
KYTX
Kyverna Therapeutics, Inc.
8.45
5.00
144.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts